new_0222_0390|RNA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0390|RNA|1|Avidity Biosciences Inc Total Current Assets (Quarterly) (USD)|Avidity Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Avidity Biosciences Inc Inventories (Quarterly) (USD)|Avidity Biosciences Inc Net PP&E (Quarterly) (USD)|Avidity Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Avidity Biosciences Inc Total Liabilities (Quarterly) (USD)|Avidity Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Avidity Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Avidity Biosciences Inc Total Deposits (Quarterly) (USD)|Avidity Biosciences Inc Book Value (Quarterly) (USD)|Avidity Biosciences Inc Retained Earnings (Quarterly) (USD)|Avidity Biosciences Inc Treasury Stock (Quarterly) (USD)|Avidity Biosciences Inc EV to Revenues|Avidity Biosciences Inc EV to Earnings|Avidity Biosciences Inc EV to Free Cash Flow|Avidity Biosciences Inc EV to Assets (Quarterly)|Avidity Biosciences Inc PS Ratio|Avidity Biosciences Inc PE Ratio|Avidity Biosciences Inc Price to Book Value|Avidity Biosciences Inc PEG Ratio|Avidity Biosciences Inc Debt to Equity Ratio|Avidity Biosciences Inc Dividend Yield|Avidity Biosciences Inc Shareholder Yield (TTM)|Avidity Biosciences Inc Percent of Shares Outstanding Short|Avidity Biosciences Inc Total Receivables (Quarterly) (USD)|Avidity Biosciences Inc Total Payables (Quarterly) (USD)|Avidity Biosciences Inc Total Capital Stock (Quarterly) (USD)|Avidity Biosciences Inc Return on Invested Capital|Avidity Biosciences Inc Quality Ratio Score|Avidity Biosciences Inc Momentum Score|Avidity Biosciences Inc Beta (1Y)|Avidity Biosciences Inc Sustainable Growth Rate (TTM)|Avidity Biosciences Inc Institutional Investor Ownership Percentage|Avidity Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Avidity Biosciences Inc Total Employees (Annual)|Avidity Biosciences Inc EPS Diluted (Quarterly) (USD)|Avidity Biosciences Inc SG&A Expense (Quarterly) (USD)|Avidity Biosciences Inc Shares Outstanding|Avidity Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Avidity Biosciences Inc Ordinary Shares Number (Quarterly)|Avidity Biosciences Inc Payout Ratio|Avidity Biosciences Inc Quick Ratio (Quarterly)|Avidity Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Avidity Biosciences Inc Stock Buybacks (Quarterly) (USD)|Avidity Biosciences Inc Effective Tax Rate (TTM)|Avidity Biosciences Inc Return on Equity|Avidity Biosciences Inc Net Income (TTM) (USD)|Avidity Biosciences Inc Revenue (TTM) (USD)|Avidity Biosciences Inc Dividend Per Share (Quarterly) (USD)|Avidity Biosciences Inc Revenue (Quarterly) (USD)|Avidity Biosciences Inc Gross Profit (Quarterly) (USD)|Avidity Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Avidity Biosciences Inc Net Income (Quarterly) (USD)|Avidity Biosciences Inc Net Interest Income (Quarterly) (USD)|Avidity Biosciences Inc Price (USD)|Avidity Biosciences Inc Total Return Price (USD)|Avidity Biosciences Inc Enterprise Value (USD)|Avidity Biosciences Inc 30-Day Average Daily Volume|Avidity Biosciences Inc 1 Year Price Returns (Daily)|Avidity Biosciences Inc Short Interest|Avidity Biosciences Inc PE Ratio (Forward)|Avidity Biosciences Inc PE Ratio (Forward 1y)|Avidity Biosciences Inc PS Ratio (Forward)|Avidity Biosciences Inc PS Ratio (Forward 1y)|Avidity Biosciences Inc Quarterly EPS Estimates (USD)|Avidity Biosciences Inc Quarterly Revenue Estimates (USD)|Avidity Biosciences Inc Quarterly EPS Surprise|Avidity Biosciences Inc Quarterly Revenue Surprise|Avidity Biosciences Inc Quarterly Actual EPS (USD)|Avidity Biosciences Inc Quarterly Actual Revenue (USD)|Avidity Biosciences Inc Revenue Estimates for Current Fiscal Year (USD)|Avidity Biosciences Inc Revenue Estimates for Next Fiscal Year (USD)|Avidity Biosciences Inc Price Target (USD)|Avidity Biosciences Inc Consensus Recommendation|Avidity Biosciences Inc Price Target Num Estimates|Avidity Biosciences Inc EPS Estimates for Current Fiscal Year (USD)|Avidity Biosciences Inc EPS Estimates for Next Fiscal Year (USD)|Avidity Biosciences Inc Research and Development Expense (Quarterly) (USD)|Avidity Biosciences Inc Reconciled Depreciation (Quarterly) (USD)|Avidity Biosciences Inc Non-Operating Interest Expense (Quarterly) (USD)|Avidity Biosciences Inc Land and Improvements (Quarterly) (USD)|Avidity Biosciences Inc Buildings and Improvements (Quarterly) (USD)|Avidity Biosciences Inc Other Properties (Quarterly) (USD)|Avidity Biosciences Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0390|RNA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0390|RNA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0390|RNA|5|91.2857142857|91.2857142857||91.2857142857||91.2857142857|91.2857142857|91.2857142857||91.2857142857|91.2857142857||1.44600938967|91.4|1.44600938967|91.4|1.44600938967||1.44600938967|1.44|91.2857142857|1.44600938967|91.4|15.2564102564|||91.2857142857|91.4||30.6666666667|30.7142857143|91.4||91.4|214|91.4|91.4|31.1875||91.2857142857|91.3333333333|91.2857142857|91.4|91.4||91.4|91.2857142857|91.3333333333||91.4444444444||91.4|91.4|91.4|1.44600938967|1.44600938967|1.44600938967|1.44584382872|1.43103448276|15.2564102564|||1.44755244755|1.44755244755|91.4|91.4|91.4|91.4|91.4|91.4|30.4705882353|43.1666666667|32.2941176471|14.4473684211|32.2941176471|28.9444444444|30.6470588235|91.4|91.4|91.4|||91.2857142857|91.2857142857||
new_0222_0390|RNA|6|7|7||7||7|7|7||7|7||426|5|426|5|426||426|225|7|426|5|39|||7|5||6|7|5||10|1|10|10|16||7|6|7|10|10||5|7|6||9||10|10|10|426|426|426|397|174|39|||286|286|10|10|5|5|5|5|17|12|17|38|17|18|17|10|10|10|||7|7||
new_0222_0390|RNA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0390|RNA|201903||||||||||||||||||||||||||||||||||20.682||-0.1232|0.912||||||-0.1231|-0.039||||||||-2.549|-2.549|-0.372||||||||||||||||||||||||1.262|0.093|0.372||||||
new_0222_0390|RNA|201906||||||||||||||||||||||||||||||||||20.682||-0.2474|1.596||||||-0.2476|0.039||||||0.224||-5.116|-5.116|-1.215||||||||||||||||||||||||2.533|0.088|1.215||||||
new_0222_0390|RNA|201909||||||||||||||||||||||||||||||||||20.682||-0.3224|0.757||||||-0.3224|||||||0.65||-6.668|-6.668|-1.462||||||||||||||||||||||||5.099|0.084|1.462||||||
new_0222_0390|RNA|201912|95.676|94.578||0.631||162.264|10.236|152.028||-65.357|-22.185||||||||||-0.0695|||||||||||||20.682||-0.5029|1.847|||30.9508||9.2397|-0.5021||||-24.734|||1.445||-10.401|-10.401|-4.338||||||||||||||||||||||||5.645|0.083|4.338|||1.755|0.102||
new_0222_0390|RNA|202003|90.257|88.751||0.558||26.676|11.341|15.335||66.002|-28.27||||||||||0.0588||||||0.002|||||||30.9508|38|-0.1966|1.964|||30.9508|-0.375|7.8257|-0.1966||||-28.27|3.677||1.358||-6.085|-6.085|0.065||||||||||||||||||||||||5.544|0.083|0.078|||1.765|0.103||
new_0222_0390|RNA|202006|353.817|352.446||0.771||25.059|11.62|13.439||330.296|-38.826||141.7835|-21.0047|-27.2858|1.9926|114.4501||3.2108||||-28.0674|1.7424|||0.004|-29.7999||||-30.6544||8.586||-1.23|2.925|37.527||37.527|-0.3144|30.331|-1.2213|-298.08||-30.5583|-33.71|4.994||1.541||-10.556|-10.556|-0.113|28.26|28.26|708.067|165194.4||653872|||||-0.3618|0.525|-240.0138|193.5238|-1.23|1.541|2.775|2.4|43.3333|1.25|3|-1.255|-1.5435|8.984|0.074|0.131|||2.052|0.102|28.19|28.8
new_0222_0390|RNA|202009|344.297|341.142||1.295||25.969|13.68|12.289||320.164|-50.265||117.4455|-18.5869|-23.8343|2.0664|112.8297||3.2995||||-28.217|4.0959|||0.004|-23.3385||||-23.7055||37.42||-0.31|3.757|37.527||37.527|-0.2755|24.9373|-0.31|||-23.6404|-38.481|6.09||1.746||-11.439|-11.439|0.027|28.15|28.15|715.243|272166.6333||1537059|||||-0.435|0.575|28.7356|203.6522|-0.31|1.746|4.025|3.8|43.3333|1.25|3|-2.45|-1.7125|9.455|0.101||||2.645|0.134|24.73|29.94
new_0222_0390|RNA|202012|331.678|328.141||1.468||27.675|14.587|13.088||306.223|-66.54||92.9159|-14.2176|-16.5045|1.8887|107.658||3.1309||||-31.0901|7.6562|||0.004|-22.964||||-23.166||37.569|82|-0.43|4.816|37.569||37.569||22.4954|-0.43|||-23.166|-44.355|6.787||2.142||-16.275|-16.275|0.018|25.52|25.52|630.6199|214089.5||2876354|||100.6573|152.1843|-0.3425|0.84|3.6496|155|-0.33|2.142|5.45|4.7|44.3333|1.25|3|-1.84|-2.4533|13.619|0.115||||2.928|0.102|22.88|24.13
new_0222_0390|RNA|202103|311.95|307.914||2.187||28.636|17.514|11.122||286.116|-90.384||62.9717|-8.2453|-9.9902|1.6271|81.1848||2.8662|-0.0791|||-36.2376|15.4604|||0.004|-23.6592||||-23.7294||37.521||-0.64|5.884|37.6003||37.6003||17.581|-0.64|||-23.7294|-62.114|8.133||2.704||-23.844|-23.844|0.016|21.81|21.81|512.1485|523346.3||5813158|||86.0958|130.1687|-0.5567|1|-14.9694|170.4|-0.64|2.704|3.5|3.5|44.3333|1.25|3|-2.7175|-3.14|20.677|0.108||||3.379|0.102|23.44|23.74
new_0222_0390|RNA|202106|287.309|279.458||2.556||26.043|16.338|9.705||264.48|-116.737||70.7951|-8.3588|-9.0054|2.2416|100.7935||3.519||||0.0833|16.2691|||0.004|-25.8449||2|1.4598|-25.8449||37.583||-0.7|6.268|37.665||37.665||17.1048|-0.7|||-25.8449|-77.911|9.199||2.607||-26.353|-26.353|0.016|24.71|24.71|651.2442|237836.3|-12.5619|6127763|||97.7115|147.7305|-0.7125|1.9375|1.7544|34.5548|-0.7|2.607|8.4108|7.1|45.75|1.4|4|-3.048|-3.596|22.706|0.147||||3.882|0.114|19.31|22.84
new_0222_0390|RNA|202109|421.958|413.029||3.22||31.04|22.418|8.622||394.877|-146.011||77.1676|-7.7501|-8.8401|1.7422|99.8532||2.9251|-1.0696|||-14.3368|12.0264|||0.005|-30.4563||2|1.2058|-30.4563||43.265||-0.68|6.612|46.897||46.897||18.424|-0.68|-165.6||-30.4563|-95.746|9.616||2.163||-29.274|-29.274|0.017|24.63|24.63|742.0441|489718.1|-12.5044|5640014|||121.2675|183.3449|-0.6775|2.125|-0.369|1.7882|-0.68|2.163|7.2257|5.5833|46.4|1.3333|5|-2.8267|-3.345|24.831|0.176||||4.44|0.123|22.5|22.33
new_0222_0390|RNA|202112|||||||||||||72.9737||-8.3596||96.3666||2.823|-1.0322||||8.4287||||||3|-0.2636||||||||||||||||||||||||23.77|23.77|701.7151|274220.8333|-6.8574|3952795|||176.9435|318.4983|-0.72|2.2333|||||9.525|6.3|49.8|1.3333|5|-2.742|-3.29||||||||16.62|14.93
new_0222_0390|RNA|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.79|2||||||||||||||||||||
new_0222_0390|RNA|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.84|2||||||||||||||||||||
new_0222_0390|RNA|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.9033|2||||||||||||||||||||
new_0222_0390|RNA|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.9667|2||||||||||||||||||||